News Agency
The Times

Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial

  • Written by PR Newswire
Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial
  • Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026
  • Appoints US-based Chief Commercial Officer, Andrew Udell
  • Xanamem's unique ability to control brain cortisol draws widespread coverage in the Australian media.

SYDNEY, Dec. 9, 2024 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that the first...

Read more: Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial

How Does Temporary Fencing Help Simplify Project Planning?

Why Does Temporary Fencing Matter During Project Planning?  A controlled boundary is essential when construction, infrastructure maintenance, demolition,  landscaping, and other projects are underway. That is when temporary fencing becomes an important  option to consider. The fencing layout affects more than site... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion